arrow
Y

Yoshitaka Imaizumi

kyoritsu seiyaku corporation
H指数:34
被引数:5,241

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan
2026-01-250
OAAI
Clinical landscape of TP73 structural variants in ATL patients
LEUKEMIA
IF13.4
2023-10-201
OAAI
Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
2023-02-169
OAAI
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105
2022-11-301
PRE
Landscape of immunoglobulin heavy chain γ gene class switch recombination in patients with adult T-cell leukemia-lymphoma
2022-11-240
OAAI
RAISING is a high-performance method for identifying random transgene integration sites
2022-06-0217
OAAI
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma
2022-04-1416
OAAI
A randomized phase 2/3 study of R-CHOP vs CHOP combined with dose-dense rituximab for DLBCL: the JCOG0601 trial
2021-02-1610
OA
Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience

莫加木单抗或来那度胺治疗异基因造血干细胞移植后复发成人t细胞白血病/淋巴瘤: 长崎移植组的经验

2020-01-2617
PREAI
Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki
2019-05-177
OAAI